Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of YangXinShi on Quality of Life and Exercise Tolerance in Chronic Heart Failure
NCT03333499Phase 1Unknown
- Sponsor
- Dalian University
- Start
- Nov 2017
- Primary completion
- Dec 2018
- Modality
- Small Molecules, Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 1, randomised trial of yangxinshi in chronic heart failure (CHF) (4 arms), sponsored by Dalian University. Primary endpoints: EQ-5D Questionnaire at 6 months and EQ-VAS at 6 months. Status: unknown.
02
Drugs
yangxinshi
03
Conditions
chronic heart failure (CHF)
Beyond the preview
Go deeper on NCT03333499.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03333499.